| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 377,262 | 326,221 | 439,113 | 441,444 | | Cost of Revenue | 332,920 | 284,610 | 387,176 | 388,121 | | | Gross Profit | 44,342 | 41,611 | 51,937 | 53,323 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,118 | 43,289 | 46,290 | 46,872 | | Non Recurring | 12,064 | 891 | 8,807 | 1,431 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,840) | (2,569) | (3,160) | 5,020 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 160 | 199 | 201 | 246 | | Earnings Before Interest And Taxes | (9,680) | (2,370) | (2,959) | 5,266 | | Interest Expense | 152 | 134 | 133 | 187 | | Income Before Tax | (9,832) | (2,504) | (3,092) | 5,079 | | Income Tax Expense | (3,373) | (885) | (383) | 1,865 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,459) | (1,619) | (2,709) | 3,214 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,459) | (1,619) | (2,709) | 3,214 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,459) | ($1,619) | ($2,709) | $3,214 |
|
0.04% Nasdaq 
0.22%
Income Statement
